Gastrointestinal stromal tumors (GISTs) are rare neoplasms, accounting for 0.1% to 3% of all
gastrointestinal malignancies. 1, 2 The most common mesenchymal tumors of the …

Gastrointestinal stromal tumors (GISTs) are relatively common mesenchymal tumors. They
originate from the wall of hollow viscera and may be found in any part of the digestive tract …

Gastrointestinal stromal tumors (GISTs) are common neoplasms of the gastrointestinal tract
that can be treated successfully using C-kit target therapy and surgery; however, imatinib …

Background To explore whether volumetric CT texture analysis (CTTA) can serve as a
potential imaging biomarker for risk stratification of small bowel gastrointestinal stromal …

Background: Currently, the incidence of gastrointestinal stromal tumors (GIST) is increasing
rapidly worldwide. Malnutrition may increase the risk of perioperative complications and …

Gastrointestinal stromal tumors (GISTs) are the most common malignant mesenchymal
neoplasms of the gastrointestinal tract. The gold standard for the diagnosis of GISTs is …

Gastrointestinal stromal tumours (GISTs) are the most common human sarcomas and are
typically located in the stomach or small intestine. Although circular RNAs (circRNAs) …

Subepithelial lesions are increasingly being identified with improved endoscopic imaging
technologies. Many of these lesions are now recognized as gastrointestinal stromal tumors …

Background. The overall risk of cardiovascular mortality (CVM) in cancer survivors has
increased with time. The trend of CVM in patients with gastrointestinal stromal tumors …

Background Most metastatic gastrointestinal stromal tumors (GISTs) develop resistance to
the first-line imatinib treatment. Recently, increased vessel density and angiogenic markers …